Global OTC Migraine Medicine Supply, Demand and Key Producers, 2023-2029

November 2024 | 112 pages | ID: G55E19245B9BEN
GlobalInfoResearch

Abstracts

The global OTC Migraine Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
One of the primary market drivers for headache medicine is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person's quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Over-the-counter (OTC) migraine medicines are non-prescription medications that can be purchased directly from a pharmacy or retail store without a doctor's prescription. These medicines are intended to provide relief from the symptoms of migraines, such as headache, nausea, and sensitivity to light and sound.
This report studies the global OTC Migraine Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for OTC Migraine Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of OTC Migraine Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global OTC Migraine Medicine total market, 2018-2029, (USD Million)
Global OTC Migraine Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: OTC Migraine Medicine total market, key domestic companies and share, (USD Million)
Global OTC Migraine Medicine revenue by player and market share 2018-2023, (USD Million)
Global OTC Migraine Medicine total market by Type, CAGR, 2018-2029, (USD Million)
Global OTC Migraine Medicine total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global OTC Migraine Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, GSK, Bayer, Haleon, Tongde Pharmacy, Huazhong Pharmaceutical, Weisen Pharmaceutical, DIAO GROUP and Jiheng Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World OTC Migraine Medicine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global OTC Migraine Medicine Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global OTC Migraine Medicine Market, Segmentation by Type

• NSAIDs
• Acetaminophen
• Others

Global OTC Migraine Medicine Market, Segmentation by Application

• Drug Stores
• Hospitals

Companies Profiled:

• Johnson & Johnson
• GSK
• Bayer
• Haleon
• Tongde Pharmacy
• Huazhong Pharmaceutical
• Weisen Pharmaceutical
• DIAO GROUP
• Jiheng Pharmaceutical
• Dirui Pharmaceutical

Key Questions Answered
1. How big is the global OTC Migraine Medicine market?
2. What is the demand of the global OTC Migraine Medicine market?
3. What is the year over year growth of the global OTC Migraine Medicine market?
4. What is the total value of the global OTC Migraine Medicine market?
5. Who are the major players in the global OTC Migraine Medicine market?
6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 OTC Migraine Medicine Introduction
1.2 World OTC Migraine Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World OTC Migraine Medicine Total Market by Region (by Headquarter Location)
  1.3.1 World OTC Migraine Medicine Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States OTC Migraine Medicine Market Size (2018-2029)
  1.3.3 China OTC Migraine Medicine Market Size (2018-2029)
  1.3.4 Europe OTC Migraine Medicine Market Size (2018-2029)
  1.3.5 Japan OTC Migraine Medicine Market Size (2018-2029)
  1.3.6 South Korea OTC Migraine Medicine Market Size (2018-2029)
  1.3.7 ASEAN OTC Migraine Medicine Market Size (2018-2029)
  1.3.8 India OTC Migraine Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 OTC Migraine Medicine Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 OTC Migraine Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World OTC Migraine Medicine Consumption Value (2018-2029)
2.2 World OTC Migraine Medicine Consumption Value by Region
  2.2.1 World OTC Migraine Medicine Consumption Value by Region (2018-2023)
  2.2.2 World OTC Migraine Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States OTC Migraine Medicine Consumption Value (2018-2029)
2.4 China OTC Migraine Medicine Consumption Value (2018-2029)
2.5 Europe OTC Migraine Medicine Consumption Value (2018-2029)
2.6 Japan OTC Migraine Medicine Consumption Value (2018-2029)
2.7 South Korea OTC Migraine Medicine Consumption Value (2018-2029)
2.8 ASEAN OTC Migraine Medicine Consumption Value (2018-2029)
2.9 India OTC Migraine Medicine Consumption Value (2018-2029)

3 WORLD OTC MIGRAINE MEDICINE COMPANIES COMPETITIVE ANALYSIS

3.1 World OTC Migraine Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global OTC Migraine Medicine Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for OTC Migraine Medicine in 2022
  3.2.3 Global Concentration Ratios (CR8) for OTC Migraine Medicine in 2022
3.3 OTC Migraine Medicine Company Evaluation Quadrant
3.4 OTC Migraine Medicine Market: Overall Company Footprint Analysis
  3.4.1 OTC Migraine Medicine Market: Region Footprint
  3.4.2 OTC Migraine Medicine Market: Company Product Type Footprint
  3.4.3 OTC Migraine Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: OTC Migraine Medicine Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: OTC Migraine Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: OTC Migraine Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: OTC Migraine Medicine Consumption Value Comparison
  4.2.1 United States VS China: OTC Migraine Medicine Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: OTC Migraine Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based OTC Migraine Medicine Companies and Market Share, 2018-2023
  4.3.1 United States Based OTC Migraine Medicine Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies OTC Migraine Medicine Revenue, (2018-2023)
4.4 China Based Companies OTC Migraine Medicine Revenue and Market Share, 2018-2023
  4.4.1 China Based OTC Migraine Medicine Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies OTC Migraine Medicine Revenue, (2018-2023)
4.5 Rest of World Based OTC Migraine Medicine Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based OTC Migraine Medicine Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies OTC Migraine Medicine Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World OTC Migraine Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 NSAIDs
  5.2.2 Acetaminophen
  5.2.3 Others
5.3 Market Segment by Type
  5.3.1 World OTC Migraine Medicine Market Size by Type (2018-2023)
  5.3.2 World OTC Migraine Medicine Market Size by Type (2024-2029)
  5.3.3 World OTC Migraine Medicine Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World OTC Migraine Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Drug Stores
  6.2.2 Hospitals
6.3 Market Segment by Application
  6.3.1 World OTC Migraine Medicine Market Size by Application (2018-2023)
  6.3.2 World OTC Migraine Medicine Market Size by Application (2024-2029)
  6.3.3 World OTC Migraine Medicine Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Details
  7.1.2 Johnson & Johnson Major Business
  7.1.3 Johnson & Johnson OTC Migraine Medicine Product and Services
  7.1.4 Johnson & Johnson OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Johnson & Johnson Recent Developments/Updates
  7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 GSK
  7.2.1 GSK Details
  7.2.2 GSK Major Business
  7.2.3 GSK OTC Migraine Medicine Product and Services
  7.2.4 GSK OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 GSK Recent Developments/Updates
  7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Bayer
  7.3.1 Bayer Details
  7.3.2 Bayer Major Business
  7.3.3 Bayer OTC Migraine Medicine Product and Services
  7.3.4 Bayer OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Bayer Recent Developments/Updates
  7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 Haleon
  7.4.1 Haleon Details
  7.4.2 Haleon Major Business
  7.4.3 Haleon OTC Migraine Medicine Product and Services
  7.4.4 Haleon OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Haleon Recent Developments/Updates
  7.4.6 Haleon Competitive Strengths & Weaknesses
7.5 Tongde Pharmacy
  7.5.1 Tongde Pharmacy Details
  7.5.2 Tongde Pharmacy Major Business
  7.5.3 Tongde Pharmacy OTC Migraine Medicine Product and Services
  7.5.4 Tongde Pharmacy OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Tongde Pharmacy Recent Developments/Updates
  7.5.6 Tongde Pharmacy Competitive Strengths & Weaknesses
7.6 Huazhong Pharmaceutical
  7.6.1 Huazhong Pharmaceutical Details
  7.6.2 Huazhong Pharmaceutical Major Business
  7.6.3 Huazhong Pharmaceutical OTC Migraine Medicine Product and Services
  7.6.4 Huazhong Pharmaceutical OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Huazhong Pharmaceutical Recent Developments/Updates
  7.6.6 Huazhong Pharmaceutical Competitive Strengths & Weaknesses
7.7 Weisen Pharmaceutical
  7.7.1 Weisen Pharmaceutical Details
  7.7.2 Weisen Pharmaceutical Major Business
  7.7.3 Weisen Pharmaceutical OTC Migraine Medicine Product and Services
  7.7.4 Weisen Pharmaceutical OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Weisen Pharmaceutical Recent Developments/Updates
  7.7.6 Weisen Pharmaceutical Competitive Strengths & Weaknesses
7.8 DIAO GROUP
  7.8.1 DIAO GROUP Details
  7.8.2 DIAO GROUP Major Business
  7.8.3 DIAO GROUP OTC Migraine Medicine Product and Services
  7.8.4 DIAO GROUP OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 DIAO GROUP Recent Developments/Updates
  7.8.6 DIAO GROUP Competitive Strengths & Weaknesses
7.9 Jiheng Pharmaceutical
  7.9.1 Jiheng Pharmaceutical Details
  7.9.2 Jiheng Pharmaceutical Major Business
  7.9.3 Jiheng Pharmaceutical OTC Migraine Medicine Product and Services
  7.9.4 Jiheng Pharmaceutical OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Jiheng Pharmaceutical Recent Developments/Updates
  7.9.6 Jiheng Pharmaceutical Competitive Strengths & Weaknesses
7.10 Dirui Pharmaceutical
  7.10.1 Dirui Pharmaceutical Details
  7.10.2 Dirui Pharmaceutical Major Business
  7.10.3 Dirui Pharmaceutical OTC Migraine Medicine Product and Services
  7.10.4 Dirui Pharmaceutical OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Dirui Pharmaceutical Recent Developments/Updates
  7.10.6 Dirui Pharmaceutical Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 OTC Migraine Medicine Industry Chain
8.2 OTC Migraine Medicine Upstream Analysis
8.3 OTC Migraine Medicine Midstream Analysis
8.4 OTC Migraine Medicine Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World OTC Migraine Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World OTC Migraine Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World OTC Migraine Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World OTC Migraine Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World OTC Migraine Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World OTC Migraine Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World OTC Migraine Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World OTC Migraine Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World OTC Migraine Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key OTC Migraine Medicine Players in 2022
Table 12. World OTC Migraine Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global OTC Migraine Medicine Company Evaluation Quadrant
Table 14. Head Office of Key OTC Migraine Medicine Player
Table 15. OTC Migraine Medicine Market: Company Product Type Footprint
Table 16. OTC Migraine Medicine Market: Company Product Application Footprint
Table 17. OTC Migraine Medicine Mergers & Acquisitions Activity
Table 18. United States VS China OTC Migraine Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China OTC Migraine Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based OTC Migraine Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies OTC Migraine Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies OTC Migraine Medicine Revenue Market Share (2018-2023)
Table 23. China Based OTC Migraine Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies OTC Migraine Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies OTC Migraine Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based OTC Migraine Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies OTC Migraine Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies OTC Migraine Medicine Revenue Market Share (2018-2023)
Table 29. World OTC Migraine Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World OTC Migraine Medicine Market Size by Type (2018-2023) & (USD Million)
Table 31. World OTC Migraine Medicine Market Size by Type (2024-2029) & (USD Million)
Table 32. World OTC Migraine Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World OTC Migraine Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World OTC Migraine Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. Johnson & Johnson Basic Information, Area Served and Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson OTC Migraine Medicine Product and Services
Table 38. Johnson & Johnson OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Johnson & Johnson Recent Developments/Updates
Table 40. Johnson & Johnson Competitive Strengths & Weaknesses
Table 41. GSK Basic Information, Area Served and Competitors
Table 42. GSK Major Business
Table 43. GSK OTC Migraine Medicine Product and Services
Table 44. GSK OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. GSK Recent Developments/Updates
Table 46. GSK Competitive Strengths & Weaknesses
Table 47. Bayer Basic Information, Area Served and Competitors
Table 48. Bayer Major Business
Table 49. Bayer OTC Migraine Medicine Product and Services
Table 50. Bayer OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bayer Recent Developments/Updates
Table 52. Bayer Competitive Strengths & Weaknesses
Table 53. Haleon Basic Information, Area Served and Competitors
Table 54. Haleon Major Business
Table 55. Haleon OTC Migraine Medicine Product and Services
Table 56. Haleon OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Haleon Recent Developments/Updates
Table 58. Haleon Competitive Strengths & Weaknesses
Table 59. Tongde Pharmacy Basic Information, Area Served and Competitors
Table 60. Tongde Pharmacy Major Business
Table 61. Tongde Pharmacy OTC Migraine Medicine Product and Services
Table 62. Tongde Pharmacy OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Tongde Pharmacy Recent Developments/Updates
Table 64. Tongde Pharmacy Competitive Strengths & Weaknesses
Table 65. Huazhong Pharmaceutical Basic Information, Area Served and Competitors
Table 66. Huazhong Pharmaceutical Major Business
Table 67. Huazhong Pharmaceutical OTC Migraine Medicine Product and Services
Table 68. Huazhong Pharmaceutical OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Huazhong Pharmaceutical Recent Developments/Updates
Table 70. Huazhong Pharmaceutical Competitive Strengths & Weaknesses
Table 71. Weisen Pharmaceutical Basic Information, Area Served and Competitors
Table 72. Weisen Pharmaceutical Major Business
Table 73. Weisen Pharmaceutical OTC Migraine Medicine Product and Services
Table 74. Weisen Pharmaceutical OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Weisen Pharmaceutical Recent Developments/Updates
Table 76. Weisen Pharmaceutical Competitive Strengths & Weaknesses
Table 77. DIAO GROUP Basic Information, Area Served and Competitors
Table 78. DIAO GROUP Major Business
Table 79. DIAO GROUP OTC Migraine Medicine Product and Services
Table 80. DIAO GROUP OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. DIAO GROUP Recent Developments/Updates
Table 82. DIAO GROUP Competitive Strengths & Weaknesses
Table 83. Jiheng Pharmaceutical Basic Information, Area Served and Competitors
Table 84. Jiheng Pharmaceutical Major Business
Table 85. Jiheng Pharmaceutical OTC Migraine Medicine Product and Services
Table 86. Jiheng Pharmaceutical OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Jiheng Pharmaceutical Recent Developments/Updates
Table 88. Dirui Pharmaceutical Basic Information, Area Served and Competitors
Table 89. Dirui Pharmaceutical Major Business
Table 90. Dirui Pharmaceutical OTC Migraine Medicine Product and Services
Table 91. Dirui Pharmaceutical OTC Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of OTC Migraine Medicine Upstream (Raw Materials)
Table 93. OTC Migraine Medicine Typical Customers
List of Figure
Figure 1. OTC Migraine Medicine Picture
Figure 2. World OTC Migraine Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World OTC Migraine Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World OTC Migraine Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World OTC Migraine Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company OTC Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company OTC Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company OTC Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company OTC Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company OTC Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company OTC Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company OTC Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 13. OTC Migraine Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World OTC Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World OTC Migraine Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States OTC Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China OTC Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe OTC Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan OTC Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea OTC Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN OTC Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India OTC Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of OTC Migraine Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for OTC Migraine Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for OTC Migraine Medicine Markets in 2022
Figure 27. United States VS China: OTC Migraine Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: OTC Migraine Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World OTC Migraine Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World OTC Migraine Medicine Market Size Market Share by Type in 2022
Figure 31. NSAIDs
Figure 32. Acetaminophen
Figure 33. Others
Figure 34. World OTC Migraine Medicine Market Size Market Share by Type (2018-2029)
Figure 35. World OTC Migraine Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World OTC Migraine Medicine Market Size Market Share by Application in 2022
Figure 37. Drug Stores
Figure 38. Hospitals
Figure 39. OTC Migraine Medicine Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source